scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00392-012-0508-3 |
P698 | PubMed publication ID | 23052331 |
P2093 | author name string | Ernst R Schwarz | |
Aldo Maggioni | |||
Alejandro Barbagelata | |||
Anita Phan | |||
Rajesh Ramineni | |||
Paulino A Alvarez | |||
Carlos Boissonnet | |||
Clay Barbin | |||
Phil Myatt | |||
P2860 | cites work | Autologous mononuclear bone marrow cells during reparative regeneratrion after acute myocardial infarction | Q83941697 |
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction | Q22250889 | ||
2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration | Q22306346 | ||
Adverse effects of biologics: a network meta-analysis and Cochrane overview | Q24234197 | ||
The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction | Q28248284 | ||
The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study | Q28286170 | ||
Inducible apoptosis as a safety switch for adoptive cell therapy | Q29617710 | ||
Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. | Q30444845 | ||
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction | Q30824170 | ||
Transcoronary transplantation of progenitor cells after myocardial infarction | Q30824315 | ||
Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial | Q33263365 | ||
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis | Q33285990 | ||
Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review | Q33340205 | ||
Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. | Q33374961 | ||
Intracoronary administration of stem cells in patients with acute myocardial infarction - angiographic follow-up. | Q33466900 | ||
Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial | Q33505911 | ||
Results of intracoronary stem cell therapy after acute myocardial infarction | Q33538384 | ||
Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas | Q33937374 | ||
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. | Q34010010 | ||
Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair | Q34103630 | ||
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group | Q34346205 | ||
Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step . | Q34550669 | ||
Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease | Q35070251 | ||
Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). | Q35772741 | ||
Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study | Q36322384 | ||
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
Cardiovascular events and re-stenosis following administration of G-CSF in acute myocardial infarction: systematic review and meta-analysis. | Q36924655 | ||
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in coll | Q37028681 | ||
Stem cell therapy is proarrhythmic | Q37336616 | ||
Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005 | Q37402737 | ||
Stem cells are not proarrhythmic: letting the genie out of the bottle. | Q37435260 | ||
Stem cell therapy for heart failure: are arrhythmias a real safety concern? | Q37496407 | ||
Cell therapy for the treatment of coronary heart disease: a critical appraisal | Q37696967 | ||
Cardiac cell therapy: lessons from clinical trials | Q37769840 | ||
Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care | Q37976396 | ||
Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions | Q38417798 | ||
Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy | Q39347068 | ||
Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl | Q40525372 | ||
Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. | Q44229341 | ||
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction | Q44392643 | ||
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure | Q44411377 | ||
Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. | Q45022812 | ||
Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction | Q45198815 | ||
Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. | Q45958753 | ||
Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety | Q46700940 | ||
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu | Q47849023 | ||
Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase | Q47860320 | ||
Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction | Q48831721 | ||
Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging | Q48946348 | ||
Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. | Q50774320 | ||
Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. | Q50776586 | ||
Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction | Q51168550 | ||
Stem cell therapy for myocardial repair: is it arrhythmogenic? | Q51783314 | ||
Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. | Q51797011 | ||
Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy. | Q53149136 | ||
The international pandemic of chronic cardiovascular disease. | Q53240008 | ||
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial | Q56610959 | ||
Lifetime Risk for Developing Congestive Heart Failure | Q57073232 | ||
Long-Term Trends in the Incidence of and Survival with Heart Failure | Q57073236 | ||
Trends in Heart Failure Incidence and Survival in a Community-Based Population | Q57540294 | ||
Lost in translation | Q59057872 | ||
Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Int | Q61942700 | ||
Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association | Q73162822 | ||
Reporting of safety data from randomised trials | Q77664569 | ||
Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in My | Q79615200 | ||
The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI) | Q79843933 | ||
Lack of additional benefit of intracoronary transplantation of autologous peripheral blood stem cell in patients with acute myocardial infarction | Q80033976 | ||
Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction | Q80246358 | ||
[Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function] | Q80374410 | ||
Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study | Q80485648 | ||
Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction | Q80673912 | ||
Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects | Q81191191 | ||
Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium | Q81845589 | ||
P433 | issue | 1 | |
P304 | page(s) | 1-10 | |
P577 | publication date | 2012-09-28 | |
P1433 | published in | Clinical Research in Cardiology | Q2665050 |
P1476 | title | Periprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review | |
P478 | volume | 102 |
Q38267653 | Investigating the role of acute mental stress on endothelial dysfunction: a systematic review and meta-analysis | cites work | P2860 |
Search more.